SCHEMBL5045168

SCHEMBL5045168

COC(C(=O)O)c1c(F)cc(-c2cc[n+]([O-])cc2)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP2C19 P33261 3/20 0.33
PTGS2 P35354 3/20 0.33
APP P05067 2/20 0.33
ANPEP P15144 2/20 0.33
CYP2C9 P11712 2/20 0.32
CYP3A4 P08684 1/20 0.32
AKR1C2 P52895 4/20 0.32
AKR1C3 P42330 3/20 0.32
PTGS1 P23219 3/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
AKR1C1 Q04828 2/20 0.31
FABP2 P12104 1/20 0.31
TSHR P16473 1/20 0.31
AKR1C4 P17516 1/20 0.31
ADRA2B P18089 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047725 0.84 LMNA (0.33) ALDH1A1GAAMEN1KMT2ATSHR
Hydrochloric Acid SCHEMBL5040718 0.73 F2 (0.43)
SCHEMBL5037863 0.72 PTGS2 (0.42) ALDH1A1GAACYP2C19PTGS2APP
SCHEMBL2352769 0.72 ALDH1A1 (0.49) ALDH1A1GAAL3MBTL1KDM4EAKR1C2
SCHEMBL2345247 0.68 PTGS2 (0.45) ALDH1A1PTGS2AKR1C2AKR1C3PTGS1
SCHEMBL5045404 0.65 CDC7 (0.41) ALDH1A1MAPTHPGD
SCHEMBL31147960 0.65 AKR1C3 (0.43) ALDH1A1GAAL3MBTL1KDM4ECYP2C19
SCHEMBL31147959 0.65 AKR1C3 (0.43) ALDH1A1GAAL3MBTL1KDM4ECYP2C19
SCHEMBL5040984 0.64 MIF (0.39) ALDH1A1GAAL3MBTL1KDM4ECYP2C19
SCHEMBL5042415 0.64 ALDH1A1 (0.44) ALDH1A1GAAL3MBTL1KDM4EAKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 ALDH1A1 519/4885GAA 1312/4885L3MBTL1 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.